Reduced HDL-cholesterol in long COVID-19: A key metabolic risk factor tied to disease severity

Reduced HDL-cholesterol in long COVID-19: A key metabolic risk factor tied to disease severity

This controlled study investigated metabolic changes in non-vaccinated individuals with Long-COVID-19, along with their connection to the severity of the disease. The study involved 88 patients who experienced varying levels of initial disease severity (mild, moderate, and severe), and a control gro...

وصف كامل

محفوظ في:
التفاصيل البيبلوغرافية
المؤلف الرئيسي: Jamila, Al-Zadjali (author)
مؤلفون آخرون: Al-Lawati, Amal (author), Al Riyami, Nafila (author), Al Farsi, Koukab (author), Al Jarradi, Najwa (author), Boudaka, Ammar (author), Al Barhoumi, Ali (author), Al Lawati, Mohsen (author), Al Khaifi, Amani (author), Musleh, Asma (author), Gebrayel, Prisca (author), Vaulont, Sophie (author), Peyssonnaux, Carole (author), Edeas, Marvin (author), Saleh, Jumana (author)
التنسيق: article
منشور في: 2024
الموضوعات:
Long-COVID-19
HDL-cholesterol
Iron
Ferritin
Metabolic changes
Disease severity
الوصول للمادة أونلاين:http://dx.doi.org/10.1016/j.clinsp.2024.100344
https://www.sciencedirect.com/science/article/pii/S1807593224000218
http://hdl.handle.net/10576/64524
الوسوم: إضافة وسم
لا توجد وسوم, كن أول من يضع وسما على هذه التسجيلة!

الانترنت

http://dx.doi.org/10.1016/j.clinsp.2024.100344
https://www.sciencedirect.com/science/article/pii/S1807593224000218
http://hdl.handle.net/10576/64524

مواد مشابهة